Cancer research includes companies engaged in scientific research on the causes, prevention, diagnosis, treatment, and potential cures for cancer. It involves many disciplines, from biology and genetics to clinical trials and drug development. These companies produce life-saving products for a rapidly growing and highly sought-after market and form strategic partnerships with global organizations. This makes them appealing to investors seeking both financial gain and support for healthcare advancements and patient outcomes.
Top losers: $Life360 Inc (360.AU)$, $Summerset Group Holdings Ltd (SNZ.AU)$ and $Qantas Airways Ltd (QAN.AU)$
Australian shares climbed on Tuesday, with the $S&P/ASX 200 (.XJO.AU)$ closing up 39.1 points at 8,231. The market rallied on news of a potential gradual approach to US tariff increas...
• The S&P 500 Index initially falls and then reverses course to close higher.
• Australian stocks recover from two-week lows Investor sentiment is moderately bullish.
• Stocks to watch: TLX, CCX, etc.
Wall Street Summary
On Monday, the S&P 500 initially fell but later climbed, ending the day higher. $NVIDIA (NVDA.US)$ fell after Biden administration ...
• U.S. stocks close lower, reversing earlier gains on Thursdays.
• Australian equities commence trading on an upbeat note on Friday, driven by surge in energy stocks due to boost in oil prices.
• Stocks to watch: IMU, LTM, etc.
Wall Street Summary
Stocks closed lower on Thursday, reversing gains made at the start of the new year. The $Dow Jones Industrial Average (.DJI.US)$closed do...
Top losers: $Telix Pharmaceuticals Ltd (TLX.AU)$, $Technology One Ltd (TNE.AU)$ and $Neuren Pharmaceuticals Ltd (NEU.AU)$
$S&P/ASX 200 (.XJO.AU)$ kicks off the new year with a broad rally, climbing 0.52% to close at 8,201.2 points.
10 out of 11 sectors close higher. This strong start across most sect...
No comment yet